Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$2.31 - $5.85 $66,990 - $169,650
-29,000 Closed
0 $0
Q3 2021

Oct 27, 2021

BUY
$4.55 - $10.36 $45,500 - $103,600
10,000 Added 52.63%
29,000 $133,000
Q2 2021

Aug 03, 2021

SELL
$5.98 - $7.51 $2,900 - $3,642
-485 Reduced 2.49%
19,000 $131,000
Q4 2020

Jan 27, 2021

SELL
$7.81 - $10.39 $1,952 - $2,597
-250 Reduced 1.27%
19,485 $157,000
Q3 2020

Oct 21, 2020

SELL
$6.34 - $10.83 $7,925 - $13,537
-1,250 Reduced 5.96%
19,735 $202,000
Q2 2020

Jul 31, 2020

BUY
$4.6 - $8.6 $6,370 - $11,911
1,385 Added 7.07%
20,985 $141,000
Q4 2019

Jan 15, 2020

BUY
$5.76 - $7.35 $112,896 - $144,060
19,600 New
19,600 $119,000
Q2 2019

Jul 11, 2019

SELL
$6.34 - $8.8 $77,031 - $106,920
-12,150 Closed
0 $0
Q1 2019

Apr 11, 2019

SELL
$6.06 - $9.0 $606 - $900
-100 Reduced 0.82%
12,150 $101,000
Q4 2018

Jan 24, 2019

SELL
$5.18 - $9.35 $4,662 - $8,415
-900 Reduced 6.84%
12,250 $68,000
Q3 2018

Oct 24, 2018

SELL
$6.0 - $11.35 $3,600 - $6,810
-600 Reduced 4.36%
13,150 $116,000
Q1 2018

Apr 17, 2018

BUY
$4.96 - $6.84 $14,880 - $20,520
3,000 Added 27.91%
13,750 $71,000
Q4 2017

Jan 19, 2018

SELL
$4.58 - $10.81 $139,690 - $329,705
-30,500 Reduced 73.94%
10,750 $55,000
Q3 2017

Oct 20, 2017

BUY
$8.25 - $10.81 $340,312 - $445,912
41,250
41,250 $446,000

Others Institutions Holding RDHL

About RedHill Biopharma Ltd.


  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.